Sophia Genetics
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products
Basic Information
- Category: biotechnology
- Website: https://www.sophiagenetics.com/
Documented Facts
- Phone: 467-025-6088 (No linked source recorded for this statement.)
- Industry (SIC): Data Processing (No linked source recorded for this statement.)
- State of Incorporation: V8 (No linked source recorded for this statement.)
- Stock ticker: SOPH (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Sophia Genetics — Official Site (official)
- Sophia Genetics on instagram (social)
- Sophia Genetics on facebook (social)
- Sophia Genetics on linkedin (social)
- SOPHiA GENETICS SA — SEC EDGAR (reference)
Citation Guidance
Explore biotechnology profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Sophia Genetics.
- Canonical profile: https://brandsource.ai/brands/sophia-genetics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/sophia-genetics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/sophia-genetics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.